Stockscreener 앱 받기
8.60
1.30%
0.11
시간 외 거래:
8.60
전일 마감가:
$8.49
열려 있는:
$8.25
하루 거래량:
139.79K
Relative Volume:
2.06
시가총액:
$186.59M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.61%
1개월 성능:
-31.47%
6개월 성능:
-24.43%
1년 성능:
+0.00%
1일 변동 폭
$8.25
$8.99
1주일 범위
$8.03
$9.09
52주 변동 폭
$4.88
$19.58
Aardvark Therapeutics Inc Stock (AARD) Company Profile
명칭
Aardvark Therapeutics Inc
전화
(858) 225-7696
주소
4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO
AARD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AARD
Aardvark Therapeutics Inc
|
8.60 | 184.17M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Aardvark Therapeutics Inc Stock (AARD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-03-10 | 개시 | BofA Securities | Buy |
| 2025-03-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-10 | 개시 | Morgan Stanley | Overweight |
| 2025-03-10 | 개시 | RBC Capital Mkts | Outperform |
Aardvark Therapeutics Inc 주식(AARD)의 최신 뉴스
Aardvark Therapeutics Inc. stock daily chart insights2025 Top Decliners & AI Optimized Trading Strategy Guides - Newser
Will Aardvark Therapeutics Inc. stock go up soonJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Published on: 2025-09-07 01:45:43 - Newser
Can Aardvark Therapeutics Inc. recover in the next quarterTrend Reversal & AI Forecast Swing Trade Picks - Newser
Developing predictive dashboards with Aardvark Therapeutics Inc. dataEarnings Miss & Breakout Confirmation Alerts - Newser
How to forecast Aardvark Therapeutics Inc. trends using time seriesTrade Entry Summary & Advanced Swing Trade Entry Plans - Newser
What high frequency data says about Aardvark Therapeutics Inc.Dollar Strength & High Conviction Investment Ideas - Newser
Can volume confirm reversal in Aardvark Therapeutics Inc.2025 Historical Comparison & AI Driven Stock Movement Reports - Newser
What MACD signals say about Aardvark Therapeutics Inc.July 2025 Breakouts & Fast Gain Swing Alerts - Newser
Candlestick signals on Aardvark Therapeutics Inc. stock todayBull Run & Weekly High Momentum Picks - Newser
Aardvark Therapeutics Inc. stock chart pattern explainedOil Prices & Free Technical Pattern Based Buy Signals - Newser
Real time breakdown of Aardvark Therapeutics Inc. stock performanceJuly 2025 Opening Moves & Verified Chart Pattern Signals - Newser
Custom watchlist performance reports with Aardvark Therapeutics Inc.Sell Signal & Precise Swing Trade Entry Alerts - Newser
Is Aardvark Therapeutics Inc. a candidate for recovery play2025 Dividend Review & Free High Accuracy Swing Entry Alerts - Newser
Is Aardvark Therapeutics Inc. stock a smart retirement pickEarnings Recap Summary & Safe Capital Growth Plans - خودرو بانک
Will Aardvark Therapeutics Inc. stock recover after earningsJuly 2025 Technicals & Community Consensus Stock Picks - خودرو بانک
Does Aardvark Therapeutics Inc. offer margin of safetyJuly 2025 Update & Capital Efficiency Focused Ideas - خودرو بانک
Statistical indicators supporting Aardvark Therapeutics Inc.’s strengthOil Prices & Consistent Growth Equity Picks - Newser
How to build a custom watchlist for Aardvark Therapeutics Inc.July 2025 Levels & Real-Time Stock Movement Alerts - Newser
Is Aardvark Therapeutics Inc. stock showing strong momentum2025 Sector Review & Expert-Curated Trade Recommendations - خودرو بانک
What’s next for Aardvark Therapeutics Inc. stock priceJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
Aardvark Therapeutics reports inducement grants under Nasdaq listing rule - TipRanks
Will Aardvark Therapeutics Inc. bounce back from current supportJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Can machine learning forecast Aardvark Therapeutics Inc. recoveryMarket Performance Recap & Stock Portfolio Risk Management - Newser
Tick level data insight on Aardvark Therapeutics Inc. volatilityPortfolio Gains Report & Risk Controlled Daily Plans - Newser
Tools to assess Aardvark Therapeutics Inc.’s risk profileJuly 2025 Sector Moves & Breakout Confirmation Alerts - Newser
Is Aardvark Therapeutics Inc. stock overvalued or fairly pricedJuly 2025 Summary & Verified Entry Point Detection - خودرو بانک
Aardvark Therapeutics (AARD): Pioneering Gut-Brain Signaling to Disrupt Obesity and Metabolic Disease Therapies - AInvest
Aardvark Therapeutics’ Strategic Position in Metabolic Disease Innovation - AInvest
Should you buy the dip on Aardvark Therapeutics Inc.July 2025 Rallies & Expert-Curated Trade Recommendations - خودرو بانک
Combining machine learning predictions for Aardvark Therapeutics Inc.Gold Moves & Verified Momentum Stock Alerts - Newser
Aardvark Therapeutics Updates Corporate Presentation on Strategy - TipRanks
Can Aardvark Therapeutics Inc. continue delivering strong returns2025 Dividend Review & Trade Opportunity Analysis Reports - خودرو بانک
Aardvark Therapeutics Inc (AARD) 재무 분석
Aardvark Therapeutics Inc (AARD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):